Please Note - Streaming News is only available to subscribers to the Active Level and above
Director Deals - (GSK)
BFN
Hal Barron, Executive Director, has re-invested 2,842 shares in the company on the 30th January 2023 at a price of $17.76. The Director now holds 540,744 shares.
Story provided by StockMarketWire.com
Director deals data provided by www.sharesmagazine.co.uk
